ICD-10 Cancellation Unlikely – Healthcare Industry Should Still Prepare

Home/ICD-10/ICD-10 Cancellation Unlikely – Healthcare Industry Should Still Prepare

ICD-10 Cancellation Unlikely – Healthcare Industry Should Still Prepare

Though the AMA has actively lobbied to stop or delay ICD-10, it notes in its newsletter AMA Wire:

A bill seeking repeal of the ICD-10 code set is now in both chambers of Congress after its introduction to the U.S. Senate last month.

American Medical Association

The Cutting Costly Codes Act of 2013, which was first introduced into the U.S. House of Representatives in April, would prohibit the U.S. Department of Health and Human Services from implementing, administering or enforcing current regulations that require the new code set to take effect Oct. 1, 2014.

“At the same time, physicians should make preparations for the new code set to avoid disastrous results if ICD-10 is rolled out as planned. Those who aren’t ready by next year’s deadline will not receive payment for their services.”

We recommend that all HIPAA Covered Entities continue to prepare for ICD-10.

(Visited 22 times, 1 visits today)
Share
By | 2016-08-11T08:45:41+00:00 June 9th, 2013|ICD-10|0 Comments

About the Author:

Michael is Managing Partner & CEO of No World Borders, a leading health care management and IT consulting firm. He leads a team that provides Cybersecurity best practices for healthcare clients, ICD-10 Consulting, Meaningful Use of Electronic Health Records. He advises legal teams as an expert witness in HIPAA Privacy and Security, medical coding and billing and usual and customary cost of care, the Affordable Care Act and benefits enrollment, white collar crime, False Claims Act, Anti-Kickback, Stark Law, Insurance Fraud, payor-provider disputes, and consults to venture capital and private equity firms on mHealth, Cloud Computing in Healthcare, and Software as a Service. He advises self-insured employers on cost of care and regulations. Arrigo was recently retained by the U.S. Department of Justice (DOJ) regarding a significant false claims act investigation. He has provided opinions on over $1 billion in health care claims and due diligence on over $4 billion in healthcare mergers and acquisitions. Education: UC Irvine - Economics and Computer Science, University of Southern California - Business, Stanford Medical School - Biomedical Informatics, Harvard Law School - Bioethics.
Loading Facebook Comments ...

Leave A Comment